Evolving Stroke Systems of Care: Stroke Diagnosis and Treatment in the Post-Thrombectomy Era

Michael J. Pajor, Opeolu M. Adeoye

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Thrombectomy became the gold-standard treatment of acute ischemic stroke caused by large-vessel occlusions (LVO) in 2015 after five clinical trials published that year demonstrated significantly improved patient outcomes. In subsequent years, advances in stroke systems of care have centered around improving access to and expanding patient eligibility for thrombectomy. The prehospital and acute stroke treatment settings have had the greatest emphasis. Numerous prehospital stroke scales now provide emergency medical services with focused physical exams to identify LVOs, and many devices to non-invasively detect LVO are undergoing clinical testing. Mobile stroke units deployed throughout Western Europe and the USA also show promising results by bringing elements of acute stroke care directly to the patient. Numerous clinical trials since 2015 have aimed to increase candidates for thrombectomy by expanding indications and the eligibility time window. Further optimizations of thrombectomy treatment have focused on the role of thrombolytics and other adjunctive therapies that may promote neuroprotection and neurorecovery. While many of these approaches require further clinical investigation, the next decade shows significant potential for further advances in stroke care.

Original languageEnglish
Pages (from-to)655-663
Number of pages9
Issue number3
StatePublished - Apr 2023


  • Large-vessel occlusion
  • Mobile stroke unit
  • Neurotherapeutics
  • Stroke
  • Thrombectomy


Dive into the research topics of 'Evolving Stroke Systems of Care: Stroke Diagnosis and Treatment in the Post-Thrombectomy Era'. Together they form a unique fingerprint.

Cite this